期刊文献+

临床药师参与多重耐药鲍曼不动杆菌肺部感染患者临床治疗的药学监护 被引量:4

Pharmaceutical Care for Medication in Multi-Resistant Acinetobacter baumannii Patient with Lungs Infection by Pharmacist Participation
下载PDF
导出
摘要 目的:分析临床药师参与多重耐药鲍曼不动杆菌肺部感染患者抗感染治疗药学监护,为合理用药提供参考。方法:临床药师参在1例多重耐药鲍曼不动杆菌肺部感染患者的治疗过程中,为医师提供药物治疗信息、分析用药情况、监护患者用药过程。结果:临床药师参与多重耐药鲍曼不动杆菌肺部感染患者抗感染治疗,疗效较显著,治疗过程中无发生明显的药物不良反应。结论:临床药师利用专业的药物知识在治疗团队中对提高疗效、保障患者用药安全方面有着积极的作用。 Objective: To analyze the pharmaceutical care by pharmacist participation for anti-infective medication in multi-resistant Acinetobacter baumannii patient with Lungs infection, and to provide a reference for rational drug use. Methods: Clinical pharmacists participate in one ease of multiple drug-resistant Acinetobacter baumannii lungs infected in patients during treatment, providing medication information and analysis for physicians and pharmacy care for patients. Results: The effect of the anti-infection treatment of multiple drug-resistant Acinetobacter baumannii pneumonia involved by clinical pharmacists was obvious and there were no significant drug reactions druing the treatment process. Conclusion: Through the use of professional knowledge to improve the efficacy and to ensure drug safety, clinical pharmacists could play an active role in the treatment team.
机构地区 宜春市人民医院
出处 《抗感染药学》 2016年第1期86-89,共4页 Anti-infection Pharmacy
关键词 临床药师 药学监护 多重耐药鲍曼不动杆菌 肺部感染患者 clinical pharmacist pharmaceutical care multi-resistant Acinetobacter baumannii, lungs infection
  • 相关文献

参考文献2

二级参考文献18

  • 1王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 2张婴元,张敬德,周乐,吴培澄,陈友娣,王宇倩,汪复.头孢哌酮-舒巴坦体外抗菌作用研究[J].中华内科杂志,1995,34(10):676-679. 被引量:52
  • 3李金钟,李中华.获得性金属β-内酰胺酶检测方法的概况[J].国际检验医学杂志,2006,27(9):830-832. 被引量:6
  • 4Walsh TR,Toleman MA, Poirel L, et al. Metallo-beta-lactamases:the quiet before the storm[J].Clin Microbiol Rev,2005,18(2):306-325.
  • 5Neuwirth C,Siebor E, Robin F, et al. First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France[J]. Antimicrob Agents Chemother, 2007,51 (12) : 4486-4488.
  • 6Garza Ramos U, Morfin Otero R, Sader HS, et al. Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95,from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico[J]. Antimicrob Agents Chemother, 2008,52(8):2943-2946.
  • 7Pasteran F,Faccone D,Petroni A, et al. Novel variant bla (VIM-11) of the metallo-beta-lactamase bla(VIM) family in a GES-1 extended-spectrum-beta-laetamase-producing Pseudomonas aeruginosa clinical isolate in Argentina[J]. Antimicrob Agents Chemother, 2005,49 : 474-475.
  • 8Juan C, Beceiro A, Gutierrez O, et al. Characterization of the new metallo-beta-lactamase VIM-13 and its integronborne gene from a Pseudomonas aeruginosa clinical isolate in Spain [J].Antimicrob Agents Chemother, 2008, 52 (10):3589 -3596.
  • 9Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases[J]. Clin Microbiol Rev, 2007,20 (a) : 440- 458.
  • 10Walther-Rasmussen J, Hφiby N. OXA type carbapenemases[J].J Antimicrob Chemother,2006,57(3) :373-383.

共引文献37

同被引文献43

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部